It was reported that during treatment with two (2) prismaflex st150 sets, blood was observed in the auto-effluent bag.During an unspecified process step of continuous renal replacement therapy, reddish effluent was observed.The blood leak detection alarm was not triggered.The set was replaced, and the event occurred for a second time.There was no report of patient injury or medical intervention associated with this event.No additional information is available.
|
Initial reporter facility name: (b)(6) hospital.Initial reporter e-mail: (b)(6).A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The device was not received for evaluation; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.Prismaflex st150 set has been temporarily approved for use in the us under emergency use authorization eua200704 to deliver crrt to treat patients in an acute care environment during the covid-19 pandemic.
|